100% Satisfaction Guaranteed!
The Solana Influenza A+B Assay is a rapid qualitative in vitro diagnostic test for the detection and differentiation of influenza A and influenza B viral RNA in nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection.
The Solana Influenza A+B Assay amplifies and detects viral RNA present in transport media containing nasopharyngeal or nasal swab specimens obtained from symptomatic patients.
- Rapid method of isothermal nucleic acid amplification that does not require thermal cycler
- Easy-to-use format, just add processed sample to rehydrate
- Eliminates the need for dedicated molecular space and costly capital equipment, allowing for testing in smaller labs
- Requires minimal training
- No freezer needed, 2˚C to 8˚C storage
- No ice or cooling block required
Solana Influenza A+B Assay Kit [48 test/kit]
California Prop 65
WARNING: This product can expose you to chemicals including arsenic, which is known to the State of California to cause cancer. For more information, visit Proposition 65
|Sample type||Nasal swabs and nasopharyngeal swabs in transport media* obtained from patients symptomatic of respiratory infection *BD/Copan VTM, Remel M4, Remel M4RT, Remel M5, Remel M6, or Copen eSwab|
|Time to results||Approximately 45 minutes|
|Reagent storage conditions||Lysis and Reaction Tubes; 2˚C to 8˚C|
|Controls storage conditions||2°C to 8°C|
|Sample preparation storage conditions||Specimens should be collected, transported, stored, and processed according to CLSI M41-A. Specimens should be stored at 2°C to 8°C until tested. Specimens collected in BD UTM, Remel M4, M4RT, M5, and M6 (3 mL) are stable at 2°C to 8°C for up to 9 days|
|Clinical Sensitivity (culture)||Influenza A: 98.6% (95% CI 96.8% to 99.4%) Influenza B: 100% (95% CI 95.7% to 100%)|
|Clinical Specificity (culture)||Influenza A: 95.1% (95% CI 93.7% to 96.3%) Influenza B: 99.3% (95% CI 98.7% to 99.6%)|
|Clinical Sensitivity (PCR)||Influenza A: 97.2% (95% CI 95.0% to 98.4%) Influenza B: 100.0% (95% CI 95.4% to 100%)|
|Clinical Specificity (PCR)||Influenza A: 96.7% (95% CI 95.4% to 97.7%) Influenza B: 98.9% (95% CI 98.2% to 99.4%)|
|LOD (Influenza A)||A/Taiwan/42/06: 7.5x102 TCID50/mL A/California/07/2009: 4.7x102 TCID50/mL A/Texas/50/2012: 6.3x100 TCID50/mL|
|LOD (Influenza B)||B/Brisbane/60/08: 8.5x101 TCID50/mL B/Massachusetts/2/2012: 3.3x101 TCID50/mL|